John Jed Kennedy Power - 03 Mar 2022 Form 4 Insider Report for CONMED Corp (CNMD)

Role
Group Executive Vice President
Signature
Sarah M. Oliker for John (Jed) Kennedy by Power of Attorney
Issuer symbol
CNMD
Transactions as of
03 Mar 2022
Net transactions value
-$585,368
Form type
4
Filing time
07 Mar 2022, 16:08:23 UTC
Previous filing
03 Mar 2022
Next filing
10 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CNMD Common Stock Options Exercise $305,316 +5,092 +52% $59.96 14,947 03 Mar 2022 Direct
transaction CNMD Common Stock Sale $734,532 -5,092 -34% $144.25 9,855 03 Mar 2022 Direct F1
transaction CNMD Common Stock Options Exercise $140,980 +1,790 +18% $78.76 11,645 03 Mar 2022 Direct
transaction CNMD Common Stock Sale $258,328 -1,790 -15% $144.32 9,855 03 Mar 2022 Direct F2
transaction CNMD Common Stock Options Exercise $81,278 +832 +8.4% $97.69 10,687 03 Mar 2022 Direct
transaction CNMD Common Stock Sale $120,083 -832 -7.8% $144.33 9,855 03 Mar 2022 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CNMD Options To Purchase Common Stock Options Exercise $0 -5,092 -49% $0.000000 5,400 03 Mar 2022 Common Stock 5,092 $59.96 Direct F4
transaction CNMD Options To Purchase Common Stock Options Exercise $0 -1,790 -32% $0.000000 3,800 03 Mar 2022 Common Stock 1,790 $78.76 Direct F5
transaction CNMD Options To Purchase Common Stock Options Exercise $0 -832 -11% $0.000000 6,768 03 Mar 2022 Common Stock 832 $97.69 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $144.25 to $144.36. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $144.26 to $144.50. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $144.26 to $144.40. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F4 The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.
F5 The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period